The authors found that RAB3C overexpression induces dystrophin expression to promote vesicle formation and packaging for increased exocytosis, is related to drug resistance and is correlated with PIK3CA/KRAS mutation status in colon cancer. Here, KRAS is linked to malignant colon neoplasm.